A successful birth of severe secondary recurrent miscarriage case after a decline of phosphatidylserine-dependent anti-prothrombin antibody by intravenous immunoglobulin administration

Journals Menu

Follow SCIRP

ISSN Print: 2160-8792
ISSN Online: 2160-8806
www.scirp.org/journal/ojog
E-mail: ojog@scirp.org

"A successful birth of severe secondary recurrent miscarriage case after a decline of phosphatidylserine-dependent anti-prothrombin antibody by intravenous immunoglobulin administration"
written by Mika Kanaya, Kunihiko Nagasawa, Tsuyoshi Baba, Shinichi Ishioka, Hideto Yamada, Toshiaki Endo, Tsuyoshi Saito,
published by Open Journal of Obstetrics and Gynecology, Vol.2 No.2, 2012

has been cited by the following article(s):

[1]	Effectiveness of high‐dose iv immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome
	Reproductive medicine and biology, 2018

Follow SCIRP

[1]	Effectiveness of high-dose i.v. immunoglobulin therapy for pregnant women with aspirin-heparin-resistant secondary antiphospholipid syndrome Reproductive Medicine and Biology, 2018 DOI:10.1002/rmb2.12080

[2]	Effectiveness of high‐dose i.v. immunoglobulin therapy for pregnant women with aspirin–heparin‐resistant secondary antiphospholipid syndrome Reproductive Medicine and Biology, 2018 DOI:10.1002/rmb2.12080